Amgen

The FDA told Amgen to test whether a quarter-dose of sotorasib worked as well as the amount on the label. It did, but the biotech is sticking to the higher dose, which earns it an extra $180,000 a year per patient.

The nation’s biggest pharmacy benefits manager has decided to cover two new drugs that lower artery-clogging cholesterol but raise concern over prices…

Federal health officials have approved the first lower-cost copy of a biotech drug to reach the U.S. market, a long-awaited milestone that could generate…

Per dose, flu shots are one of the cheapest vaccines you can get. That’s according to the CDC, which insists paying $30 at a pharmacy is a bargain, the…

In "Fiscal Footnote: Big Senate Gift to Drug Maker,” the New York Times reported that key Senate lawmakers inserted a paragraph into Section 632 of the…